Scientists at The University of Texas at Austin, in collaboration with researchers from the University of North Carolina at Chapel Hill and the National Institutes of Health, have discovered a strategy to fight back against ...
Mar 5, 2025
0
32
A live-attenuated tuberculosis (TB) vaccine candidate in development at Texas Biomedical Research Institute (Texas Biomed) elicits a much more balanced and effective immune response compared to the existing vaccine used across ...
Mar 5, 2025
1
37
Cornell researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both COVID-19 and influenza, and broader immunity to different flu strains.
Mar 3, 2025
0
108
The malaria parasite is still killing almost half a million people every year. A project has now identified a gene that holds out the prospect of a safe, effective live vaccine. The study is published in PLOS One.
Feb 28, 2025
0
68
Researchers at the University of Liverpool have conducted a large-scale analysis that sheds light on the critical steps needed to combat the vertical transmission of chronic hepatitis B virus (HBV) in Africa.
Feb 27, 2025
0
23
A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials, as part of a successful collaboration between three leading Australian research institutions.
Feb 20, 2025
0
51
A vaccination program has cut hospital admissions for a respiratory virus among older people in Scotland by nearly two-thirds.
Feb 17, 2025
0
129
Vaccinations alone may not be enough to protect people with compromised immune systems from infection, even if the vaccine has generated the production of antibodies, new research from the University of Cambridge has shown.
Feb 12, 2025
0
278
Scientists at the Institute for Systems Biology (ISB) have uncovered key insights into how T cells—the body's frontline immune soldiers—respond to infections like COVID-19. Their research suggests that the disease fighting ...
Feb 10, 2025
0
54
Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune ...
Feb 5, 2025
0
195
